Uterine leiomyoma
is a relatively common condition occurring in a majority of African American
and Caucasian women by age 50. Magnetic resonance imaging of the pelvis with
contrast is the modality of choice when evaluating uterine tumors. We report a
case of a patient with a four-day history of intra-menstrual vaginal bleeding
who underwent magnetic resonance imaging of the pelvis that suggested the tumor
was a leiomyosarcoma, the malignant counterpart of leiomyoma. Therefore, the
patient underwent pre-operative uterine artery embolization to decrease blood
loss with exploratory laparotomy, resection of pelvic mass and dilation and
curettage. Pathologic evaluation of the mass returned a diagnosis of leiomyoma.
Magnetic resonance imaging evaluation of leiomyomata remains difficult. Further
development of imaging parameters could improve diagnosis of benign uterine
fibroids.
References
[1]
Baird, D.D., Dunson, D.B., Hill, M.C., Cousins, D. and Schectman, J.M. (2003) High Cumulative Incidence of Uterine Leiomyoma in Black and White Women: Ultrasound Evidence. American Journal of Obstetrics & Gynecology, 188, 100-107. http://dx.doi.org/10.1067/mob.2003.99
[2]
Bell, S.W., Kempson, R.L. and Hendrickson, M.R. (1994) Problematic Uterine Smooth Muscle Neoplasms. A Clinicopathologic Study of 213 Cases. The American Journal of Surgical Pathology, 18, 535-558. http://dx.doi.org/10.1097/00000478-199406000-00001
[3]
Tavassoli, F.A. and Devilee, P. (2003) World Helath Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. 3rd Edition, IARC Press, 233-242.
[4]
Dinh, T.A., Oliva, E.A., Fuller Jr., A.F., Lee, H. and Goodman, A. (2004) The Treatment of Uterine Leiomyosarcoma. Results from a 10-Year Experience (1990-1999) at the Massachusetts General Hospital. Gynecologic Oncology, 92, 648-652. http://dx.doi.org/10.1016/j.ygyno.2003.10.044
[5]
Tanaka, Y.O., Nishida, M., Tsunoda, H., Okamoto, Y. and Yoshikawa, H. (2004) Smooth Muscle Tumors of Uncertain Malignant Potential and Leiomyosarcomas of the Uterus: MR Findings. Journal of Magnetic Resonance Imaging, 20, 998-1007. http://dx.doi.org/10.1002/jmri.20207
[6]
Rha, S.E., Byun, J.Y., Jung, S.E., Lee, S.L., Cho, S.M., Hwang, S.S., Lee, H.G., Namkoong, S.-E. and Lee, J.M. (2003) CT and MRI of Uterine Sarcomas and Their Mimickers. AJR, 181, 1369-1374. Http://dx.doi.org/10.2214/ajr.181.5.1811369
[7]
Sahdev, A., Sohaib, S.A., Jacobs, I., Shepherd, J.H., Oram, D.H. and Reznek, R.H. (2001) MR Imaging of Uterine Sarcomas. AJR, 177, 1307-1311. http://dx.doi.org/10.2214/ajr.177.6.1771307
[8]
Cornfeld, D., Israel, G., Marel, M., Weinreb, J., Schwartz, P. and McCarthy, S. (2010) MRI Appearance of Mesenchymal Tumor s of the Uterus. EJR, 74, 241-249. http://dx.doi.org/10.1016/j.ejrad.2009.03.005
[9]
Sato, K., Yuasa, N., Fujita, M. and Fukushima, Y. (2014) Clinical Application of Diffusion-Weighted Imaging for Preoperative Differentiation between Uterine Leiomyoma and Leiomyosarcoma. American Journal of Obstetrics & Gynecology, 210, 368.e1-8.
[10]
Avritscher, R., Iyer, R.B., Ro, J. and Whitman, G. (2001) Lipoleiomyoma of the Uterus. AJR, 177, 856. http://dx.doi.org/10.2214/ajr.177.4.1770856